Mebendazole restores gefitinib activity by inducing DNA damage in resistant lung cancer cells
Mebendazole combined with gefitinib increased DNA damage and suppressed growth in preclinical models of gefitinib-resistant non-small cell lung cancer.
Mebendazole combined with gefitinib increased DNA damage and suppressed growth in preclinical models of gefitinib-resistant non-small cell lung cancer.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine